Reaction: Meloxicam to 1 product

Reaction
Reaction type
Not Available
Direction
Not Available
Major circulating metabolite?
No
Spontaneous?
No
Activity
unknown
References
  1. Prasad GS, Srisailam K, Sashidhar RB: Metabolic inhibition of meloxicam by specific CYP2C9 inhibitors in Cunninghamella blakesleeana NCIM 687: in silico and in vitro studies. Springerplus. 2016 Feb 24;5:166. doi: 10.1186/s40064-016-1794-4. eCollection 2016. [PubMed:27026863]
  2. FDA approved products: Mobic (meloxicam) oral tablets [Link]
Comments
The bacteria Cunninghamella blakesleeana is reported to be involved in the biotransformation of meloxicam.
Enzymes
Not Available